http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022232900-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db8acd71f5994544bda6df3f27a3f51e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09B11-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-544
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09B23-083
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6911
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-04
filingDate 2021-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73d7ec4dcd31532b05b5507a906565ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8ec0957bc74949ac20c8a23e3894a4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52ac7a139385269b826f14bb28ce47cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b4e30ef62518366390b8ca97edc95dc
publicationDate 2022-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2022232900-A1
titleOfInvention Liposomes displaying a glycan ligand for cd33 and their use in the treatment of alzheimer's disease
abstract The present application provides a liposomal composition that multivalently displays a specific glycan ligand, or combination of specific glycan ligands, to specifically target CD33 on microglial cells. Multivalent engagement of CD33 with glycan ligands in the liposomal composition are useful in modulating microglial cell function, particularly as a therapeutic for the preventing, treating or delaying progression of Alzheimer's disease.
priorityDate 2021-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012018377-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018009825-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451463395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID452110
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID933
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12483
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1015
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23688921
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163606
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID83433
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5458428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519929
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56927689
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10236
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587765
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487501
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415794038
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419572499
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID221493
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507060
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538728
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554054
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID554810
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15061530
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID54209
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521634

Total number of triples: 56.